NDRG2 and breast carcinoma: Analyzing KMP data showed a favorable RFS (P<0.001) and OS (P = 0.014) in luminal A breast cancer patients with abundant NDRG2 mRNA expression underlining the known tumor suppressive function of NDRG2 (S1A and S1B Fig).